PE20061242A1 - Combinaciones terapeuticas que comprenden un bloqueador de canales de calcio de accion prolongada del tipo de la dihidropiridina y una estatina - Google Patents
Combinaciones terapeuticas que comprenden un bloqueador de canales de calcio de accion prolongada del tipo de la dihidropiridina y una estatinaInfo
- Publication number
- PE20061242A1 PE20061242A1 PE2006000193A PE2006000193A PE20061242A1 PE 20061242 A1 PE20061242 A1 PE 20061242A1 PE 2006000193 A PE2006000193 A PE 2006000193A PE 2006000193 A PE2006000193 A PE 2006000193A PE 20061242 A1 PE20061242 A1 PE 20061242A1
- Authority
- PE
- Peru
- Prior art keywords
- statine
- dihydropyridine
- long
- type
- calcium channel
- Prior art date
Links
- YNGDWRXWKFWCJY-UHFFFAOYSA-N 1,4-Dihydropyridine Chemical compound C1C=CNC=C1 YNGDWRXWKFWCJY-UHFFFAOYSA-N 0.000 title 1
- 229940127291 Calcium channel antagonist Drugs 0.000 title 1
- 239000000480 calcium channel blocker Substances 0.000 title 1
- DFVFTMTWCUHJBL-BQBZGAKWSA-N statine Chemical compound CC(C)C[C@H](N)[C@@H](O)CC(O)=O DFVFTMTWCUHJBL-BQBZGAKWSA-N 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
- 208000031226 Hyperlipidaemia Diseases 0.000 abstract 2
- -1 2- [4- (DIPHENYLMETHYL) -1-PIPERAZINYL] ETHYL METHYL Chemical class 0.000 abstract 1
- 206010002383 Angina Pectoris Diseases 0.000 abstract 1
- 201000001320 Atherosclerosis Diseases 0.000 abstract 1
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- ANEBWFXPVPTEET-UHFFFAOYSA-N manidipine Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN2CCN(CC2)C(C=2C=CC=CC=2)C=2C=CC=CC=2)C1C1=CC=CC([N+]([O-])=O)=C1 ANEBWFXPVPTEET-UHFFFAOYSA-N 0.000 abstract 1
- 229960003963 manidipine Drugs 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
SE REFIERE A UNA COMPOSICION FARMACEUTICA QUE COMPRENDE A) 2-[4-(DIFENILMETIL)-1-PIPERAZINIL]ETIL METIL ESTER DE ACIDO (±)-1,4-DIHIDRO-2,6-DIMETIL-4-(3-NITROFENIL)-3,5-PIRIDINDICARBOXILICO O MANIDIPINA QUE SE ENCUENTRA EN UNA CANTIDAD DE 5MG A 30MG; Y B) UNA ESTATINA QUE SE ENCUENTRA EN UNA CANTIDAD DE 10MG A 80MG. DICHA COMPOSICION TIENE LA FORMA FARMACEUTICA DE TABLETA Y ES UTIL EN EL TRATAMIENTO DE ATEROSCLEROSIS, HIPERTENSION COMBINADA CON HIPERLIPIDEMIA, ANGINA DE PECHO
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05003382 | 2005-02-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20061242A1 true PE20061242A1 (es) | 2006-12-21 |
Family
ID=36118210
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2006000193A PE20061242A1 (es) | 2005-02-17 | 2006-02-16 | Combinaciones terapeuticas que comprenden un bloqueador de canales de calcio de accion prolongada del tipo de la dihidropiridina y una estatina |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US20080070926A1 (es) |
| EP (1) | EP1848425B1 (es) |
| JP (1) | JP2008530153A (es) |
| KR (1) | KR20070111468A (es) |
| CN (1) | CN101115480A (es) |
| AR (1) | AR052914A1 (es) |
| AT (1) | ATE520397T1 (es) |
| AU (1) | AU2006215855A1 (es) |
| BR (1) | BRPI0607142A2 (es) |
| CA (1) | CA2597498A1 (es) |
| EA (1) | EA200701460A1 (es) |
| ES (1) | ES2369787T3 (es) |
| MX (1) | MX2007009779A (es) |
| PE (1) | PE20061242A1 (es) |
| WO (1) | WO2006087117A1 (es) |
| ZA (1) | ZA200706702B (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080057590A1 (en) * | 2006-06-07 | 2008-03-06 | Mickey Urdea | Markers associated with arteriovascular events and methods of use thereof |
| WO2010102158A1 (en) * | 2009-03-04 | 2010-09-10 | Walter Howard Peschel | Compositions and treatment regimes for reducing inflammation, end-organ injury, and/or systemic endotoxemia |
| JP6421535B2 (ja) * | 2014-10-14 | 2018-11-14 | 日亜化学工業株式会社 | 発光装置及び表示部並びに制御回路 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GT199800126A (es) * | 1997-08-29 | 2000-01-29 | Terapia de combinacion. | |
| US20050267197A1 (en) * | 2004-05-25 | 2005-12-01 | Roger Berlin | Compositions containing policosanol and HMG-Co-A reductase inhibitor and their pharmaceutical uses |
-
2006
- 2006-02-06 JP JP2007555496A patent/JP2008530153A/ja active Pending
- 2006-02-06 CN CNA2006800043388A patent/CN101115480A/zh active Pending
- 2006-02-06 EA EA200701460A patent/EA200701460A1/ru unknown
- 2006-02-06 BR BRPI0607142-2A patent/BRPI0607142A2/pt not_active IP Right Cessation
- 2006-02-06 KR KR1020077017533A patent/KR20070111468A/ko not_active Application Discontinuation
- 2006-02-06 MX MX2007009779A patent/MX2007009779A/es not_active Application Discontinuation
- 2006-02-06 US US11/884,329 patent/US20080070926A1/en not_active Abandoned
- 2006-02-06 WO PCT/EP2006/001024 patent/WO2006087117A1/en active Application Filing
- 2006-02-06 ZA ZA200706702A patent/ZA200706702B/xx unknown
- 2006-02-06 CA CA002597498A patent/CA2597498A1/en not_active Abandoned
- 2006-02-06 AU AU2006215855A patent/AU2006215855A1/en not_active Abandoned
- 2006-02-06 ES ES06706679T patent/ES2369787T3/es active Active
- 2006-02-06 EP EP06706679A patent/EP1848425B1/en active Active
- 2006-02-06 AT AT06706679T patent/ATE520397T1/de active
- 2006-02-16 PE PE2006000193A patent/PE20061242A1/es not_active Application Discontinuation
- 2006-02-17 AR ARP060100586A patent/AR052914A1/es unknown
-
2009
- 2009-09-28 US US12/567,865 patent/US20100022556A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0607142A2 (pt) | 2009-08-11 |
| US20080070926A1 (en) | 2008-03-20 |
| MX2007009779A (es) | 2007-09-26 |
| EP1848425A1 (en) | 2007-10-31 |
| EP1848425B1 (en) | 2011-08-17 |
| CA2597498A1 (en) | 2006-08-24 |
| CN101115480A (zh) | 2008-01-30 |
| KR20070111468A (ko) | 2007-11-21 |
| JP2008530153A (ja) | 2008-08-07 |
| ATE520397T1 (de) | 2011-09-15 |
| ES2369787T3 (es) | 2011-12-07 |
| ZA200706702B (en) | 2008-11-26 |
| US20100022556A1 (en) | 2010-01-28 |
| AU2006215855A1 (en) | 2006-08-24 |
| EA200701460A1 (ru) | 2008-02-28 |
| AR052914A1 (es) | 2007-04-11 |
| WO2006087117A1 (en) | 2006-08-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2008001668A1 (es) | Compuestos derivados de piperidin o piperazin carboxamida; composicion farmaceutica; y su uso en el tratamiento de la obesidad, hipercolesterolemia, dislipidemia, hipertrigliceridemia, higado graso, fibrosis hepatica, hepatitis, entre otras, mediadas por dgat. | |
| PE20010168A1 (es) | Sal mutua de amlodipino y atorvastatina | |
| EA200702674A1 (ru) | Способ лечения атеросклероза, дислипидемий и связанных с ними состояний и фармацевтические композиции | |
| HN2006014095A (es) | Forma cristalina ortorrombica del maleato de asenapina | |
| MX2010004028A (es) | 4-[3-(4-ciclopropancarbonil-piperacin-1-carbonil)-4-fluoro-bencil ]-2h-ftalacin-1-ona. | |
| DK2049475T3 (da) | Cyclohexyl-substituerede pyrrolidinoner som inhibitorer af 11-beta-hydroxysteroid dehydrogenase1 | |
| PE20120812A1 (es) | Compuestos vinil indazolilo | |
| PE20100083A1 (es) | Combinaciones de drogas que comprenden un inhibidor de dgat y un agonista de ppar | |
| MEP50608A (en) | 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazol-5-carbonyl)-pyridine-2-yl-amino]-propionic acid ethyl ester methane sulphonate and use thereof as a medicament | |
| ECSP067110A (es) | Derivados de 2-carbamida-4-feniltiazol, su preparación y su aplicación en terapéutica | |
| EA201391318A1 (ru) | Твердые формы 3-(5-амино-2-метил-4-оксо-4н-хиназолин-3-ил)пиперидин-2,6-диона и их фармацевтические композиции и применение | |
| FI20090094A (fi) | Olmesartaanimedoksomiilin ja amlodipiinin kiinteä annostusmuoto | |
| CY1111010T1 (el) | Ενωσεις τετραϋδρο-ναφθαλενο-1-καρβοξυλικου οξεος υποκατεστημενου με πιπεριδινη ή πιπεραζινη που αναστελλουν την mtp | |
| NO20041266L (no) | Piperidinderivater som kan anvendes som CCR5-antagonister | |
| RS53138B (en) | 4- [2- (4-METHYLPHENYLSULPHANYL) PHENYL] PIPERIDINE FOR THE TREATMENT OF INJURED INTENTION SYNDROME (IBS). | |
| PE20061242A1 (es) | Combinaciones terapeuticas que comprenden un bloqueador de canales de calcio de accion prolongada del tipo de la dihidropiridina y una estatina | |
| BRPI0716698A2 (pt) | Composto, composição farmacêutica e uso de um composto | |
| ECSP045498A (es) | "difenilazetidinonas sustituidas en anillo, metodo para su producción, medicamentos que comprenden estos compuestos y su uso" | |
| AR073891A1 (es) | Derivados de isoquinolinona antagonistas de receptores nk3, composiciones farmaceuticas que los contienen y uso de los mismos en el tratamiento de psicosis, alzheimer y otras enfermedades. | |
| BRPI0820985A2 (pt) | Composto derivado de 5-aminociclometil-oxazondin-2-ona, medicamento e composição farmacêutica que os contém e uso dos mesmos | |
| DK1798234T3 (da) | Farmaceutisk sammensætning omfattende temozolomidester | |
| AP2001002345A0 (en) | Mutual prodrugs of amlodipine and atorvastatin. | |
| UY31469A1 (es) | Nuevos hidratos de difenilazetidinona cristalinos, medicamentos que comprenden a estos compuestos y uso de los mismos | |
| ITBO20060009U1 (it) | Vite per effettuare la sintesi di una frattura. | |
| BRPI0610156A2 (pt) | forma micronizada de um composto, forma purificada i do composto, kit, padrão de referência, e, método de preparaçao de uma composição farmacêutica. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |